In Nigeria, 20% of women wish to use family planning and reproductive health services, but do not have access to them (USAID 2016). While family planning services and products are available at many public and private facilities, only 11% of women nationwide currently use a modern contraceptive method (NPC 2014). Along with male condoms and pills, injectables are among the most popular methods. However, they are more difficult to access because a trained healthcare worker must administer it with a needle and syringe. Launched in Nigeria in 2014, Sayana® Press is an all-in-one injectable contraceptive designed to overcome barriers to accessing family planning. The unique injection system eliminates the need for a needle and syringe, and enables health workers to administer the injection with basic training. With its ease of application and efficacy, widely distributing Sayana Press is the latest effort to expand contraceptive choice and access for all Nigerian women.

The subcutaneous depot medroxyprogesterone acetate (DMPA-SC) injectable contraceptive was introduced in South West Nigeria in 2015 through private sector channels. The introduction included community-based distribution and was supported by a social marketing approach. From program monitoring and evaluation, aimed at understanding performance, market reach and other process measures, we identify lessons learned to inform future scale-up efforts. We synthesized the findings from a core set of key performance indicators collected through different methods: (1) implementer performance indicators, (2) phone survey of DMPA-SC users (n=541) with a follow-up after 3 months (n=342) and (3) in-depth interviews with 57 providers and 42 users of DMPA-SC